Abrdn Healthcare Investors (HQH)

$15.95

-0.29

(-1.79%)

Market is closed - opens 7 PM, 15 Apr 2024

Insights on Abrdn Healthcare Investors

  • Increasing Revenue

    Revenue is up for the last 3 quarters, 2.81M → 75.23M (in $), with an average increase of 77.7% per quarter

  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, 83.16M → -26.82M (in $), with an average decrease of 132.3% per quarter

  • Vs KKR

    In the last 1 year, Kkr & Co. L.p. has given 87.4% return, outperforming this stock by 97.6%

  • Vs APO

    In the last 3 years, Apollo Asset Management Inc has given 83.2% return, outperforming this stock by 117.7%

Performance

  • $15.93
    $16.24
    $15.95
    downward going graph

    0.16%

    Downside

    Day's Volatility :1.94%

    Upside

    1.79%

    downward going graph
  • $13.57
    $17.20
    $15.95
    downward going graph

    14.92%

    Downside

    52 Weeks Volatility :21.1%

    Upside

    7.27%

    downward going graph

Returns

PeriodAbrdn Healthcare InvestorsRussel 2000Index (Russel 2000)
3 Months
-7.48%
0.0%
0.0%
6 Months
2.84%
0.0%
0.0%
1 Year
-10.19%
-0.7%
-0.7%
3 Years
-34.47%
-21.3%
-21.3%

Highlights

Market Capitalization
806.4M
Book Value
$18.84
Dividend Share
1.61
Dividend Yield
9.87%
Earnings Per Share (EPS)
1.09
PE Ratio
14.96
PEG Ratio
0.0
Profit Margin
547.37%
Operating Margin TTM
-21.92%
Return On Assets TTM
-0.08%
Return On Equity TTM
6.1%
Revenue TTM
10.3M
Revenue Per Share TTM
0.21
Quarterly Revenue Growth YOY
8.1%
Gross Profit TTM
8.3M
Diluted Eps TTM
1.09
Quarterly Earnings Growth YOY
-0.67
EPS Estimate Current Year
0.0
EPS Estimate Next Year
0.0
EPS Estimate Current Quarter
0.0
EPS Estimate Next Quarter
0.0

Analyst Recommendation

Technicals Summary

Sell

Neutral

Buy

Abrdn Healthcare Investors is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Abrdn Healthcare Investors
Abrdn Healthcare Investors
-4.83%
2.84%
-10.19%
-34.47%
-20.77%
Blackstone Inc
Blackstone Inc
-1.07%
18.11%
44.71%
58.29%
247.41%
Kkr & Co. L.p.
Kkr & Co. L.p.
0.46%
61.24%
87.42%
83.19%
316.66%
Blackrock, Inc.
Blackrock, Inc.
-5.61%
20.14%
10.42%
-4.7%
68.95%
Apollo Asset Management Inc
Apollo Asset Management Inc
0.11%
26.22%
69.4%
122.62%
280.02%
Brookfield Corp
Brookfield Corp
-4.38%
19.78%
20.92%
-13.42%
22.79%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Abrdn Healthcare Investors
Abrdn Healthcare Investors
14.96
14.96
0.0
0.0
0.06
0.0
0.1
18.84
Blackstone Inc
Blackstone Inc
68.63
68.63
1.78
4.93
0.13
0.06
0.03
9.48
Kkr & Co. L.p.
Kkr & Co. L.p.
24.92
24.92
1.32
4.86
0.09
0.02
0.01
25.83
Blackrock, Inc.
Blackrock, Inc.
21.46
21.46
2.52
41.2
0.14
0.03
0.03
264.96
Apollo Asset Management Inc
Apollo Asset Management Inc
13.75
13.75
1.37
7.75
0.32
0.02
0.02
22.27
Brookfield Corp
Brookfield Corp
64.23
64.23
NA
4.82
0.03
0.02
0.01
27.36
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Abrdn Healthcare Investors
Abrdn Healthcare Investors
NA
$806.4M
-20.77%
14.96
547.37%
Blackstone Inc
Blackstone Inc
Buy
$153.9B
247.41%
68.63
18.1%
Kkr & Co. L.p.
Kkr & Co. L.p.
Buy
$90.7B
316.66%
24.92
20.0%
Blackrock, Inc.
Blackrock, Inc.
Buy
$116.6B
68.95%
21.46
30.81%
Apollo Asset Management Inc
Apollo Asset Management Inc
Buy
$64.7B
280.02%
13.75
15.8%
Brookfield Corp
Brookfield Corp
Buy
$59.8B
22.79%
64.23
1.15%

Company Information

tekla life sciences investors is a closed-ended equity mutual fund launched and managed by tekla capital management llc. the fund invests in public equity markets across the globe. it seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries. the fund primarily invests in growth stocks of small cap companies. it employs fundamental analysis with a focus on factors such as market position for services or products, experience of business management, technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. the fund benchmarks the performance of its portfolio against the nasdaq biotech index and the s&p 500 index. it was form

Organization
Abrdn Healthcare Investors
Employees
0
CEO
Dr. Daniel R. Omstead M.S, Ph.D.
Industry
Miscellaneous

FAQs